Pharmaceutical companies operate in an increasingly complex regulatory and business environment where safety is the top concern. Drug development and the corresponding legal demand for documentation is a long running process requiring significant attention to detail.

The 6th annual World Drug Safety Congress is the leading event for drug safety regulators and service providers, and kicks off tomorrow in Boston for two days of industry knowledge sharing. The event’s strategic focus provides an insightful look at the detection, analysis and prevention of adverse drug reactions with case studies, industry experiences and global regulatory coverage of developments.

This year’s Congress will feature discussions from leaders in the drug and pharmaceutical industry, and attendees can expect to gain a further understanding on hot issues such as:

-Insights into the challenges, potential solutions and future directions of the drug safety industry

-Necessary understanding of global regulatory developments

-How to create a more patient-centric safety strategy

-Debates on the biggest issues affecting the drug safety sector

To address drug development operational challenges, the pharmaceutical industry continues to introduce new software applications that operate in isolation and increase the administrative burden on the rest of the organization which often works against the intended goals of the applications. Appian’s cross-industry modern Work Platform simplifies the way these companies create IT applications, allowing them to deliver immediate value to business users, go live faster than commercial off-the-shelf applications, and easily make modifications to adhere with frequent changes in regulatory compliance.

In addition to this two day industry symposium, pharmaceutical process solutions will take center stage during Appian World 2014. Michael Robbins, Associate Director, Technology & Information, Clinical Sciences at Sanofi, will deliver a main stage presentation discussing how the global healthcare leader is using Appian’s integration of data, collaboration, mobility and process to drive the transition away from point solutions to an enterprise-wide focus on case management. This presentation will include a look at the successes the company has already achieved across its Clinical R&D and Pharmacovigilance business units.

If you will be in attendance for the World Drug Safety Congress, be sure to stop by the Appian booth in the exhibitor’s hall. There is still time to register for Appian World 2014, so be sure to sign up today to take part in this tremendous pharmaceutical use case example as well as others across multiple industry verticals!